3694 Federal Register / Vol. 89, No. 13 / Friday, January 19, 2024 / Notices 

filed on behalf of, and (4) whether it 

contains CBI. If it contains CBI, it must 

comply with the marking and other 

requirements set out below in this 

notice relating to CBI. Submitters of 

written documents (other than oral 

hearing statements) are encouraged to 

include a short summary of their 

position or interest at the beginning of 

the document, and a table of contents 

when the document addresses multiple 

issues. 

Confidential Business Information: 

Any submissions that contain CBI must 

also conform to the requirements of 

section 201.6 of the Commission’s Rules 

of Practice and Procedure (19 CFR 

201.6). Section 201.6 of the rules 

requires that the cover of the document 

and the individual pages be clearly 

marked as to whether they are the 

‘‘confidential’’ or ‘‘nonconfidential’’ 

version, and that the CBI is clearly 

identified by means of brackets. All 

written submissions, except for CBI, 

will be made available for inspection by 

interested persons. 

As requested by the Trade 

Representative, the Commission will not 

include any CBI in its report. However, 

all information, including CBI, 

submitted in this investigation may be 

disclosed to and used by: (i) the 

Commission, its employees and offices, 

and contract personnel (a) for 

developing or maintaining the records 

of this or a related proceeding, or (b) in 

internal investigations, audits, reviews, 

and evaluations relating to the 

programs, personnel, and operations of 

the Commission, including under 5 

U.S.C. appendix 3; or (ii) U.S. 

government employees and contract 

personnel for cybersecurity purposes. 

The Commission will not otherwise 

disclose any CBI in a way that would 

reveal the operations of the firm 

supplying the information. 

Summaries of Written Submissions: 

Persons wishing to have a summary of 

their position included in the report 

should include a summary with their 

written submission on or before March 

22, 2024, and should mark the summary 

as having been provided for that 

purpose. The summary should be 

clearly marked as ‘‘summary for 

inclusion in the report’’ at the top of the 

page. The summary may not exceed 500 

words and should not include any CBI. 

The summary will be published as 

provided if it meets these requirements 

and is germane to the subject matter of 

the investigation. The Commission will 

list the name of the organization 

furnishing the summary and will 

include a link where the written 

submission can be found. 

By order of the Commission. 

Issued: January 16, 2024. 

Lisa Barton, 

Secretary to the Commission. 

[FR Doc. 2024–00999 Filed 1–18–24; 8:45 am] 

BILLING CODE 7020–02–P 

INTERNATIONAL TRADE 

COMMISSION 

[Investigation Nos. 731–TA–1602, 1604– 

1606 (Final)] 

Tin Mill Products From the 

Netherlands, Taiwan, Turkey, and the 

United Kingdom Termination of 

Investigations 

AGENCY: United States International 

Trade Commission. 

ACTION: Notice. 

SUMMARY: On January 10, 2024, the 

Department of Commerce published 

notice in the Federal Register of 

negative final determinations of less 

than fair value (LTFV) in connection 

with the subject investigations 

concerning the Netherlands, Taiwan, 

Turkey, and the United Kingdom. 

Accordingly, the antidumping duty 

investigations concerning tin mill 

products from the Netherlands, Taiwan, 

Turkey, and the United Kingdom 

(Investigation Nos. 731–TA–1602, 1604– 

1606 (Final)) are terminated. 

DATES: January 10, 2024. 

FOR FURTHER INFORMATION CONTACT: 

Caitlyn Hendricks-Costello (202–205– 

2058), Office of Investigations, U.S. 

International Trade Commission, 500 E 

Street SW, Washington, DC 20436. 

Hearing-impaired individuals are 

advised that information on this matter 

can be obtained by contacting the 

Commission’s TDD terminal on 202– 

205–1810. Persons with mobility 

impairments who will need special 

assistance in gaining access to the 

Commission should contact the Office 

of the Secretary at 202–205–2000. 

General information concerning the 

Commission may also be obtained by 

accessing its internet server (https://

www.usitc.gov). The public record for 

these investigations may be viewed on 

the Commission’s electronic docket 

(EDIS) at https://edis.usitc.gov. 

Notice of these determinations was 

published in the Federal Register on 

January 10, 2024 at 89 FR 1524, 89 FR 

1526, 89 FR 1520, and 89 FR 1535. 

Authority: These investigations are 

being terminated under authority of title 

VII of the Tariff Act of 1930 and 

pursuant to section 207.40(a) of the 

Commission’s Rules of Practice and 

Procedure (19 CFR 207.40(a)). This 

notice is published pursuant to section 

201.10 of the Commission’s rules (19 

CFR 201.10). 

By order of the Commission. 

Issued: January 12, 2024. 

Sharon Bellamy, 

Supervisory Hearings and Information 

Officer. 

[FR Doc. 2024–00911 Filed 1–18–24; 8:45 am] 

BILLING CODE 7020–02–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–1311] 

Bulk Manufacturer of Controlled 

Substances Application: Arista 

Biologicals 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Arista Biologicals has applied 

to be registered as a bulk manufacturer 

of basic class(es) of controlled 

substance(s). Refer to SUPPLEMENTARY

INFORMATION listed below for further 

drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may submit 

electronic comments on or objections to 

the issuance of the proposed registration 

on or before March 19, 2024. Such 

persons may also file a written request 

for a hearing on the application on or 

before March 19, 2024. 

ADDRESSES: The Drug Enforcement 

Administration requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 

field on the web page or attach a file for 

lengthier comments. Please go to 

https://www.regulations.gov and follow 

the online instructions at that site for 

submitting comments. Upon submission 

of your comment, you will receive a 

Comment Tracking Number. Please be 

aware that submitted comments are not 

instantaneously available for public 

view on https://www.regulations.gov. If 

you have received a Comment Tracking 

Number, your comment has been 

successfully submitted and there is no 

need to resubmit the same comment. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.33(a), this 

is notice that on November 28, 2023, 

Arista Biologicals, 1101 Hamilton 

Street, Allentown, Pennsylvania 18101– 

1043 applied to be registered as a bulk 

manufacturer of the following basic 

class(es) of controlled substance(s): 


ddrumheller on DSK120RN23PROD with NOTICES1